59 results on '"Ahluwalia N"'
Search Results
2. WS01.04 Real-world outcomes in people with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) with up to three years of follow-up
3. Objective randomised blinded investigation of therapeutic ablation versus cardioversion for persistent atrial fibrillation- outcomes of the feasibility
4. Exploring smartphone ownership, patient behaviour, and potential bias in wearables research for atrial fibrillation
5. The influence of subclavian ansae stimulation on cardiac hemodynamics and electrophysiology in atrial fibrillation- exploring a novel target for neuromodulation in atrial fibrillation (SAS-AF study)
6. Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization
7. Episode-level characteristics of atrial fibrillation are associated with symptomatic events
8. 137 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 48-week results of an open-label extension study
9. 133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study
10. Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
11. 169 A phase 4, fully decentralized clinical trial to evaluate physical activity and cough frequency in patients with cystic fibrosis using wearable technology
12. Transseptal puncture for left atrial ablation: risk factors for cardiac tamponade and a proposed causative classification system
13. 163 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and at least one F508del alleles: 96-week interim results from an open-label extension study
14. 170 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study
15. 185 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating or residual function mutation
16. Early results of the novel radiofrequency balloon ablation catheter for pulmonary vein isolation
17. Erratum for Long‐term outcomes of index cryoballoon ablation or point‐by‐point radiofrequency ablation in patients with atrial fibrillation and systolic heart failure. J Cardiovasc Electrophysiol. 2021;32:941–948.
18. 562: Elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least 1 F508del allele: Interim results from a Phase 3 open-label extension study
19. Long-term outcomes of catheter ablation for ventricular arrhythmias in post- myocarditis patients; Insights from a meta-analysis of current datv
20. Long‐term outcomes of index cryoballoon ablation or point‐by‐point radiofrequency ablation in patients with atrial fibrillation and systolic heart failure
21. Sleep and the control of breathing
22. Sleep and the Control of Breathing
23. P504VT ablation outcomes and predictors in a UK population- validating existing predictors and novel markers
24. Catheter Management Across Patients with Hematologic Malignancies and Catheter-Related Blood Stream Infections: A Systematic Review
25. The ICU and Hospital Environment: Perspectives of Visitors to the ICU
26. The Association Between Nutritional Risk Index and ICU Mortality Across Hematologic Malignancy Patients with Acute Respiratory Failure
27. An Open-Label Extension (OLE) study of Tezacaftor/Ivacaftor (TEZ/IVA) in patients (PTS) ≥ 12 years with cystic fibrosis (CF) Homozygous for F508DEL-CFTR (F/F) or Heterozygous for F508DEL-CFTR and a residual function mutation (F/RF)
28. Doege–Potter Syndrome
29. OP0209 Soluble Ephrin-B2 Ectodomain Contributes to the Pathogenesis of Systemic Sclerosis
30. Trends in overweight prevalence among 11-, 13- and 15-year-olds in 25 countries in Europe, Canada and USA from 2002 to 2010
31. Fruit and vegetable consumption trends among adolescents from 2002 to 2010 in 33 countries
32. Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes
33. PWE-105 Biological World Of Ibd, Is It Only Safe In Tertiary Care Centres?
34. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: A 6-year prospective study
35. Dietary patterns, inflammation and the metabolic syndrome
36. A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies
37. Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study
38. O90 Apport des biomarqueurs de l’adiosité, de l’inflammation et de la fonction endothéliale dans la prédiction du diabète de type 2 au sein de la cohorte SU.VI.MAX
39. Prevention of overweight in preschool children: results of kindergarten-based interventions
40. Association of macronutrient intake patterns with being overweight in a population-based random sample of men in France
41. A rare infection of the gastric mucosa
42. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample
43. Effects of erythropoietin therapy on iron absorption in chronic renal failure
44. Alterations in mood after changing to a low-fat diet
45. Spot ferritin assay for serum samples dried on filter paper
46. Evaluation of gastric antral motor performance in patients with dysmotility-like dyspepsia using real-time high-resolution ultrasound
47. Effect of distension and feeding on phasic changes in human proximal gastric tone.
48. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy.
49. Iron deficiency and anemia of chronic disease in elderly women: a discriminant-analysis approach for differentiation
50. Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.